A Phase II Trial of Ribociclib (LEE011) Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube or Peritoneum (GOG-3026)

Investigator: Aparna Kamat, MD

Study Coordinator: Jaya Kamath

Status: Enrolling

ClinicalTrials.gov Number: NCT03673124

Phone: 713.441.6616

Protocol Number: Pro00021786


The study evaluates the response to treatment with Ribociclib and Letrozole in patients with recurrent low grade serous cancer of the ovary, fallopian tube or peritoneum.
More to Explore